Biomarkers
Measurable biological molecules (in blood, urine, tears, etc.) whose presence signals disease such as cancer, enabling detection and targeted therapy.
As defined in 77 | Azra Raza on The Way We Should Fight Cancer
Other definitions
Measurable biological indicators that reflect the state of health in specific systems or organs; used in Blueprint to enable organs to 'speak with data' about their needs and condition
Bryan Johnson in conversation with Kunal Shah | CRED curious
Where it comes up · 13
- I Tried To Make My Face Younger6 claims
- “I feel like I’m 25 again” - Dana White’s $120,000 Health Protocol4 claims
- Biotech’s Chief Evangelist3 claims
- 252 - Are We Alone In The Universe3 claims
- Bryan Johnson: Kernel Brain-Computer Interfaces | Lex Fridman Podcast #1862 claims
- Bryan Johnson in conversation with Kunal Shah | CRED curious2 claims
- Anti-Aging Millionaire: This Habit Ruins Men! - Biohacking Routine To Feel 18 Again | Bryan Johnson2 claims
- 77 | Azra Raza on The Way We Should Fight Cancer2 claims
and 5 more
Most important claims · 10 of 30Search all claims for “Biomarkers” →
- Because oxygen is so chemically reactive that any free oxygen on a planet would react away to zero in little time, a stable atmospheric supply of oxygen (or other unstable molecules like methane or phosphine) is a powerful biomarker indicating that life is constantly producing it, which is where the real answers about extraterrestrial life will come from as we study exoplanet atmospheres.252 - Are We Alone In The Universe
- Encountering a phenomenon you cannot explain and immediately concluding it is alien craft is an unjustified inferential leap; the skeptic is content to say 'I don't know what it is' without building the bridge to 'it's aliens,' and the burden of proof rests on those making the extraordinary claim, not on those who decline to explain it.252 - Are We Alone In The Universe
- The challenge with watching Dana's protocol is that none of the therapies presented have specified what biomarkers are being isolated or what effects are being measured, meaning one could spend a lifetime doing things without knowing if they actually work.“I feel like I’m 25 again” - Dana White’s $120,000 Health Protocol
- The experimental approach to caloric restriction optimization (starting with 22% deficit, then testing whether 10% deficit maintains biomarkers) demonstrates a general principle for evaluating any therapeutic intervention: finding the minimum effective dose.I Tried To Make My Face Younger
- Caloric restriction to 1,950 calories per day (22% reduction from 2,500 maintenance calories) produced excellent biomarkers within two years, reducing fat including facial fat, despite causing substantial weight loss and gaunt appearance.I Tried To Make My Face Younger
- It would be valuable to know Dana's biomarker improvements (e.g., triglyceride reduction) at the end of the protocol to verify whether the claimed subjective improvements (feeling 25 years old) correspond with objective physiological changes“I feel like I’m 25 again” - Dana White’s $120,000 Health Protocol
- Facial fat is a critical perceptual cue for assessing youthfulness; people judge age primarily from facial appearance rather than from biomarkers, creating a disconnect where someone with excellent health markers can appear old or unhealthy due to facial volume loss.I Tried To Make My Face Younger
- Treating early disease is fundamentally different from treating late disease: killing a million cells rather than 150 billion means a targeted laser could replace radiation, and if cancer-specific biomarkers existed, immune killer cells could be armed to distinguish cancer from normal cells—unlike current CAR T therapy, which kills every cell expressing the marker.77 | Azra Raza on The Way We Should Fight Cancer
- Clinical trials still follow the randomized placebo-controlled design and p-value 0.05 standard used for decades, and AI and machine learning could reduce time, cost, and redundancy while increasing the chance of success by better finding responders.Biotech’s Chief Evangelist
- Regulatory science is not advancing as fast as medical science, so regulators should adopt novel biostatistics, biomarkers, and creative trial designs for rare diseases while keeping the gold standard of safety and efficacy.Biotech’s Chief Evangelist